WHO ICTRP trial
Procalcitonin monitor and Duration of Antibiotic therapy among Community…
TCTR20250216013 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20250216013 |
|---|---|
| Public title | Procalcitonin monitor and Duration of Antibiotic therapy among Community acquired sepsis, a Randomized Controlled Trial |
| Scientific title | Procalcitonin monitor and Duration of Antibiotic therapy among Community acquired sepsis, a Randomized Controlled Trial |
| Primary sponsor | Roche Diagnostics (Thailand) |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Thailand |
| Conditions | Community acquired sepsis Community acquired septic shock Procalcitonin Community-Acquired Infections Sepsis Duration of Therapy Anti-Bacterial Agents;Procalcitonin Community-Acquired Infections Sepsis Duration of Therapy Anti-Bacterial… |
| Interventions | Procalcitonin levels were monitored on days 0, 2, and 5 of therapy. The treatment plan and duration of antibiotic were determined by the primary physician.,No procalcitonin monitoring. The treatment plan and duration of antibiotic were… |
| Registration date | Feb 16, 2025 |
| Target size | 180 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: